Key Highlights
- Stem dropped roughly 38% in data for the November 18, 2026 session after lowering 2026 Revenue guidance to USD 132 million to USD 142 million, down from USD 140 million to USD 190 million.
- Prenetics dropped about 37% once it expanded its projected second-half adjusted EBITDA loss, while Quanterix lost roughly 28% following the exit of its chief executive.
- Auna declined 12.37% on a softer EBITDA view, and Universal Technical Institute slid 8.59% after hours as its fiscal 2027 plan trimmed profit.
- Across the five cases, the market penalised updates that pushed profitability or growth further out.
1. Stem (NYSE:STEM) and Its Shrinking Revenue Base
Stem (NYSE:STEM) absorbs the most enduring blow because its Business is contracting while its exchange listing comes under strain. The software and services supplier for solar and battery storage trimmed its 2026 revenue outlook to USD 132 million through USD 142 million, down from USD 140 million through USD 190 million, and reduced its year-end Recurring Revenue goal to USD 50 million through USD 55 million from USD 65 million through USD 70 million. Those reductions stem from withdrawing from managed services agreements and battery hardware resales, together with the USD 10 million disposal of its Athena software to Voltus. Third quarter sales dropped 4% to USD 36.7 million, under roughly USD 40.3 million that analysts had penciled in, and orders declined to USD 27.6 million. A few positives emerged. Adjusted EBITDA climbed to USD 7.1 million, non-GAAP gross Margin hit 58%, PowerTrack software recurring revenue rose 14% to USD 44.4 million, and full-year adjusted EBITDA guidance moved up to USD 15 million through USD 20 million. Results were released on November 16, after which the stock lost 12.05% during the following session and a further 20.81% after hours, meaning the roughly 38% decline may cover more than one trading day. Cash stood at USD 36.9 million. The firm has received an exchange letter regarding Market Value and equity, and it has started a strategic review.
2. Prenetics (NASDAQ:PRE) and a Costly Growth Bet
Prenetics (NASDAQ:PRE) slid roughly 37%, to around USD 9.39 from USD 16.33, and places second because the reset is a conscious trade of profit for expansion, an arrangement investors doubt will be repaid. The firm, which now concentrates on its IM8 wellness supplement label, booked third quarter revenue of USD 64.1 million, roughly 3.3 times the prior-year figure and a touch above guidance. IM8 provided USD 62.9 million, and gross margin reached 64%. The concern lay in the profit view: the expected second-half adjusted EBITDA loss widened to USD 30 million through USD 35 million from USD 8 million through USD 12 million as Marketing spend accelerates. Acquisition marketing totalled roughly USD 39.3 million during the quarter, compared with USD 35.7 million, and the adjusted EBITDA loss came to USD 12.7 million. Management confirmed fiscal 2026 IM8 revenue of USD 215 million through USD 222 million, and it has set a 2027 goal of USD 400 million or more. Cash and current financial Assets total USD 111.5 million, which provides room to fund the drive. Investors clearly question whether heavy spending to win customers will eventually pay off. Fourth quarter IM8 sales, forecast at USD 73 million through USD 80 million, and the cost of acquiring each customer are the upcoming checkpoints for the strategy.
3. Quanterix (NASDAQ:QTRX) and an Abrupt Change at the Top
Quanterix (NASDAQ:QTRX), a producer of highly sensitive protein detection instruments used in neurology research, dropped roughly 28% after chief executive Everett Cunningham stepped down on the morning of November 18, effective right away, to pursue another role. Chief commercial officer James Gute, who came aboard in August, has taken the interim chief executive post, and the board has engaged a search firm to weigh internal and outside candidates. The company upheld the forecast it had offered on November 9 alongside third quarter results, which had already disappointed investors with a larger loss and fourth quarter guidance under consensus. Quanterix sits third because keeping the outlook intact cushions the financial blow, yet a sudden Leadership exit so soon after a soft report invites doubts about strategy and execution. With a market value of about USD 136 million, the decline is a painful hit for shareholders. Cunningham will remain available to assist the transition through December 11. Smaller technology and tools firms also had a rough session overall. Upland Software fell roughly 29% and Skillsoft about 20% with no company news. For Quanterix, the watch list includes whether the reaffirmed guidance survives the fourth quarter and how promptly a permanent leader is appointed. A strong outside hire could let the stock recoup some of its losses.
4. Auna (NYSE:AUNA) and Improving Cash Generation
Auna (NYSE:AUNA) finished down 12.37% on November 18, the session after third quarter results, and places fourth because its cash generation is strengthening even though Earnings are flat. The Latin American health care operator maintained its currency-neutral revenue growth forecast of 10% to 14% for 2026, but now anticipates adjusted EBITDA roughly flat or modestly lower, having earlier aimed for double-digit expansion. Currency-neutral revenue advanced 10% to PEN 1.33 billion, while adjusted EBITDA contracted by 4.6%, reaching PEN 231 million, and the Colombian segment's EBITDA dropped 30%. Much of the damage traces to termination of an unprofitable oncology risk-sharing agreement in Colombia, although price ceilings set by Colombian regulators persist. This marks the second reset, following an October investor event that knocked the shares down about 16% in early trading. The Balance Sheet is trending in the right direction. Free Cash Flow for the year to date climbed 95% to PEN 626 million, cutting Leverage to 3.5 times EBITDA against a medium-term goal under 3.0 times. Net finance costs increased to PEN 112 million from PEN 72 million, so interest still consumes much of the operating profit. A firmer dollar and soft Latin American currencies on November 18 represent an extra hazard for a firm that reports in soles.
5. Universal Technical Institute (NYSE:UTI) and Campus Investment
Universal Technical Institute (NYSE:UTI) declined 8.59% after hours on November 18 and ranks last because its reset reflects spending to expand rather than soft enrolment. The provider of Training for automotive, diesel, aviation, welding and healthcare professionals set fiscal 2027 revenue guidance at USD 925 million through USD 945 million, but projects Net Income of just USD 0 through USD 5 million, down from USD 33.6 million in fiscal 2026. Adjusted EBITDA is projected at USD 100 million through USD 106 million once roughly USD 35 million of spending on new campuses and programs is absorbed. The fourth quarter was sound. Revenue rose 6.0% to USD 235.9 million, the quarterly adjusted EBITDA figure reached USD 42.5 million, a 15.5% increase, and starts by new students went up 3.3% to 12,513. Four fresh campuses are planned in fiscal 2027, located in Salt Lake City, Houston, Atlanta and Greater Phoenix, with as many as 12 by fiscal 2029. Management aims for revenue above USD 1 billion and adjusted EBITDA nearing USD 150 million in fiscal 2028. USD 320.8 million of cash and Liquid assets against USD 114.3 million of Debt supports the program. The after-hours sell-off signals that investors are unwilling to wait two years while earnings contract. Regulatory approvals and federal student aid rules are the chief hazards, and trading on November 19 will reveal whether the decline holds.
Summary of the Five Resets
Of the five guidance and leadership resets on November 18, Stem seems poised for the most durable harm as revenue contracts amid a strategic review and an exchange notice. Prenetics is wagering on expensive growth, Quanterix must Fill its chief executive role, Auna's cash generation is improving despite flat EBITDA, and Universal Technical Institute is exchanging near-term profit for campus growth.






Please wait processing your request...